Does EVEROLIMUS Cause Mucosal inflammation? 558 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 558 reports of Mucosal inflammation have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 1.4% of all adverse event reports for EVEROLIMUS.
558
Reports of Mucosal inflammation with EVEROLIMUS
1.4%
of all EVEROLIMUS reports
96
Deaths
199
Hospitalizations
How Dangerous Is Mucosal inflammation From EVEROLIMUS?
Of the 558 reports, 96 (17.2%) resulted in death, 199 (35.7%) required hospitalization, and 38 (6.8%) were considered life-threatening.
Is Mucosal inflammation Listed in the Official Label?
Yes, Mucosal inflammation is listed as a known adverse reaction in the official FDA drug label for EVEROLIMUS.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Mucosal inflammation?
METHOTREXATE (3,352)
CYCLOPHOSPHAMIDE (2,535)
DOXORUBICIN (1,939)
VINCRISTINE (1,594)
ETOPOSIDE (1,591)
FLUOROURACIL (1,481)
RITUXIMAB (1,364)
CYTARABINE (1,337)
CAPECITABINE (1,262)
CARBOPLATIN (1,259)
Which EVEROLIMUS Alternatives Have Lower Mucosal inflammation Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE